Stockwinners Market Radar for August 22, 2021 - Earnings, Upgrades downgrades, option trades, Best Stock Advisory Service |
UAL... | Hot Stocks20:11 EDT Fly Intel: Top five weekend stock stories - Catch up on the weekend's top five stories with this list compiled by The Fly: 1. The U.S. Defense Department ordered U.S. airlines to provide 18 planes to transport evacuees, saying the extra capacity will help military aircraft focus on operations in and out of Kabul, Bloomberg's Tony Czuczka reported. Activation of the Civil Reserve Air Fleet program involves four planes from United Airlines (UAL), three each from American Airlines (AAL), Atlas Air (AAWW), Delta Air Lines (DAL) and Omni Air and two from Hawaiian Airlines (HA), Pentagon spokesman John Kirby said in a statement Sunday. 2. PayPal (PYPL) will allow customers in the UK to buy, sell and hold bitcoin and other cryptocurrencies starting this week, Reuters' Anna Irrera reported. The roll-out, which marks the first international expansion of PayPal's cryptocurrencies services outside of the United States, could inspire further mainstream adoption of the new asset class, the author wrote. 3. Big Tech has hit a perilous moment but it won't last, Eric Savitz and Max Cherney wrote in this week's edition of Barron's. The five megacaps - Apple (AAPL), Microsoft (MSFT), Alphabet (GOOG), Amazon (AMZN), and Facebook (FB) - still have the best business models on the planet, and their stocks look relatively cheap, the author noted. Investors should own them all, even if the regulatory headwinds take a while to abate, the publication added. 4. Disney's (DIS) "Free Guy" earned another $18.8M in its second outing for a 10-day domestic total of $58.8M. Overseas, the movie grossed $17.1M from 46 markets as it crossed the $100M mark globally to end Sunday with a worldwide cume of $111.9M. 5. Stem (STEM), Jefferies (JEF) and Box (BOX) saw positive mentions in this week's edition of Barron's.
|
BGNE | Hot Stocks19:44 EDT BeiGene announces acceptance of sBLA in China for Tislelizumab - BeiGene announced that the Center for Drug Evaluation of the China National Medical Products Administration has accepted a supplemental Biologics License Application for anti-PD-1 antibody tislelizumab in combination with chemotherapy as a first-line treatment for patients with recurrent or metastatic nasopharyngeal cancer. The sBLA is supported by clinical results from a randomized, double-blind, Phase 3 clinical trial RATIONALE 309 to evaluate the efficacy and safety of tislelizumab combined with gemcitabine and cisplatin versus placebo combined with gemcitabine and cisplatin as a first-line treatment for patients with recurrent or metastatic NPC. The primary endpoint of this trial is progression-free survival as assessed by independent review committee in the intention-to-treat population; secondary endpoints include overall survival, IRC-assessed overall response rate and duration of response, and investigator-assessed PFS. A total of 263 Asian patients were enrolled and randomized 1:1 to either the tislelizumab plus chemotherapy arm or the placebo plus chemotherapy arm. As announced in May 2021, RATIONALE 309 met the primary endpoint of PFS at the planned interim analysis. The safety profile of tislelizumab was consistent with its known risks, with no new safety signals identified with the addition of chemotherapy. BeiGene expects to present results from the RATIONALE 309 trial at an upcoming medical conference.
|
PSFE | Hot Stocks15:34 EDT Paysafe to acquire viafintech - Paysafe announced that it has signed a definitive agreement to acquire market-leading German fintech company, viafintech, in an all-cash transaction. Following the sale of their shares to Paysafe, viafintech's majority shareholder - Glory Ltd. - will enter into a new strategic partnership with Paysafe. The two companies have signed a referral agreement that enables Glory to offer paysafecard, one of Paysafe's leading eCash solutions, as a form of payment within its in-store payments kiosks, and, in turn, for Paysafe to offer Glory's cash technology solutions to its merchants around the world. Meanwhile, GRENKE BANK AG, which has been providing viafintech's German bank license and proven regulatory framework since 2017, as well as being a shareholder of the company, will continue to provide the same banking service going forward. The transaction is expected to close over the coming months, subject to customary closing conditions and in accordance with applicable laws and regulations. Until that time, the two organizations will continue to operate independently.
|